Eli Lilly and Company (LLY): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 1.333,721 US Dollar | 20 | 6 | 3 | 1 | 1 |
| #Shares | Short [%] | Short Ratio |
| 891.357.065 | 0,78 | 3 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Eli Lilly and Company
Mitarbeiter 50.000
Handelsplatz NYSE
Ticker Symbol LLY
IPO Datum 1978-01-13
Adresse Lilly Corporate Center, Indianapolis, IN, United States, 46285
Webseite https://www.lilly.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. David A. Ricks | Chairman, President & CEO |
| 2 | Mr. Lucas E. Montarce | Executive VP & CFO |
| 3 | Dr. Daniel M. Skovronsky M.D., Ph.D. | Chief Scientific & Product Officer and President of Lilly Research Laboratories |
| 4 | Ms. Anat Hakim J.D. | Executive VP, General Counsel & Secretary |
| 5 | Mr. Jacob S. Van Naarden | Executive VP, President of Lilly Oncology & Head of Corporate Business Development |
| 6 | Mr. Donald A. Zakrowski | Senior VP of Finance & Chief Accounting Officer |
| 7 | Mr. Diogo Rau | Executive VP and Chief Information & Digital Officer |
| 8 | Mr. Michael Czapar | Senior Vice President of Investor Relations |
| 9 | Mr. Eric Dozier | Executive VP & Chief People Officer |
| 10 | Mr. Ilya Yuffa | Executive VP and President of Lilly USA & Global Customer Capabilities |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Lilly Endowment Inc | 10,10% | 116,03 Mrd. USD |
| 2 | BlackRock Inc | 7,58% | 87,01 Mrd. USD |
| 3 | Vanguard Capital Management, LLC | 6,01% | 68,96 Mrd. USD |
| 4 | PNC Financial Services Group Inc | 5,76% | 66,12 Mrd. USD |
| 5 | State Street Corp | 4,06% | 46,66 Mrd. USD |
| 6 | FMR Inc | 3,19% | 36,67 Mrd. USD |
| 7 | Capital Research Global Investors | 2,34% | 26,89 Mrd. USD |
| 8 | Vanguard Portfolio Management, LLC | 2,34% | 26,87 Mrd. USD |
| 9 | Geode Capital Management, LLC | 2,28% | 26,17 Mrd. USD |
| 10 | Morgan Stanley - Brokerage Accounts | 1,82% | 20,90 Mrd. USD |
| 11 | Capital World Investors | 1,78% | 20,49 Mrd. USD |
| 12 | T. Rowe Price Associates, Inc. | 1,56% | 17,92 Mrd. USD |
| 13 | JPMorgan Chase & Co | 1,41% | 16,23 Mrd. USD |
| 14 | NORGES BANK | 1,29% | 14,78 Mrd. USD |
| 15 | Bank of America Corp | 1,26% | 14,52 Mrd. USD |
| 16 | Wellington Management Company LLP | 1,23% | 14,17 Mrd. USD |
| 17 | State Farm Mutual Automobile Ins Co | 1,21% | 13,86 Mrd. USD |
| 18 | PRIMECAP Management Company | 1,03% | 11,82 Mrd. USD |
| 19 | Northern Trust Corp | 0,99% | 11,33 Mrd. USD |
| 20 | The Goldman Sachs Group Inc | 0,86% | 9,86 Mrd. USD |